News

Bell Biosystems declared the results of their latest preclinical safety study at the Biotech Showcase in San Francisco. The study managed to comply with USP <151> pyrogenicity…
Read More...

Miraca Life sciences declared that it intends to change its name to inform Diagnostics with effect from immediate Avista Capital partners had acquired the company in November. The new…
Read More...

TAI diagnostics that oversees the health of transplanted organs announced the final closing of $10 million Series A preferred equity financing that will aid ongoing research and…
Read More...

Attune Medical has acquired 510 (k) clearance from the US Food and Drug Administration for new EnsoETM that administers tube feeds medication while cooling or warming patients at the…
Read More...

Aimmune Therapeutics announced its plans for the upcoming year to report top-line results in February from a pivotal phase 3 PALISADE trial of AR101 for peanut allergy following the…
Read More...

IT solutions to the global life sciences market, Instem announces the purchase of  Provantis preclinical software solution suite by  Guangdong Lewwin Pharmaceutical Research Institute…
Read More...

Octapharma USA declared Neil Herson to come on board to join as Senior VP of National Accounts and market access. Former ASD Healthcare, Neil possesses 25 years of global pharmaceutical…
Read More...

Novaliq announces randomizing patients in its SEECASE Phase 2 clinical trial of NOV03 for treating dry eye disease. Novaliq is a pharmaceutical company delivering drugs that transforms…
Read More...

Mitochondrial organisations comprising of the The Foundation for Mitochondrial Medicine (FMM), MitoAction, the Mitochondrial Medicine Society (MMS) and the United Mitochondrial Disease…
Read More...

After successful completion of pre-clinical safety studies for MIV-818 which is Medivir AB’s liver targeted nucleotide prodrug for diagnosing hepatocellular carcinoma and other forms of…
Read More...

Clinical-stage Immunology Company asserted appointment of Sterna Biologicals as the Chief Executive Officer who has over 25 years of experience in life science specifically in areas of…
Read More...

Acercus pharmaceuticals declare exclusive distributor and license agreement with Innovus Pharmaceuticals. UriVarx is a Natural Health Product (NHP) that alleviates symptoms of…
Read More...

On having received $ 38 million Series A financing by Maxim Merchant Capital, Alveo technologies to embark on curation of efficient and cost-effective disease diagnostic devices aiding…
Read More...

Shanghai Sinobioway Sunterra Biotechnology (SSSB) and F1 oncology initiate new development, manufacturing, and supply to finish a new cGMP manufacturing facility in Shenzhen with the…
Read More...

Takeda Pharmaceuticals and Denali therapeutics asserted that they have collaborated to develop and commercialize up to three specified therapeutic product candidates for…
Read More...

Celgene and Impact biomedicines signed an agreement that enumerates acquisition of Impact Biomedicines by Celgene to develop fedratinib for myelofibrosis and Polycythemia Vera. As per…
Read More...

A generic pharmaceutical company Leading Pharma, LLC that manufactures and distributes drug chains, wholesalers declared that it became a successful recipient of $ 40 million of growth…
Read More...

Semnur Pharmaceuticals announced the commencement of phase 3 clinical trials in the U.S to evaluate its product SP-102 in patients suffering from lumbar radicular pain/sciatica. It is…
Read More...

Biopharmaceutical company Kala pharmaceuticals into development and commercialization of product candidates incorporating the usage of MPP technology declared that the New drug…
Read More...

A Shanghai-based integrated biopharmaceutical company, Jiangsu Hengrui Medicine and Arcutis, a Menlo Park, CA-based Biotechnology Company declared licensing agreement to commercialize…
Read More...